Paula Cannon, Ph.D.

Distinguished Professor of Molecular Microbiology & Immunology, University of Southern California

Paula Cannon is a Distinguished Professor in the Department of Molecular Microbiology & Immunology at the University of Southern California’s Keck School of Medicine where she leads a research team that studies viruses, stem cells, and gene therapy. Her work has led to the development of a gene editing approach to treating HIV, which is currently in clinical trials. Her recent contributions are focused on using CRISPR/Cas9 to engineer hematopoietic stem cells and B cells, with a view to long-term control of viral infections. She also studies the entry process of highly pathogenic viruses, including Ebola and Lassa fever, and is developing inhibitors for SARS-CoV-2. Dr. Cannon is an active member of the American Society of Gene & Cell Therapy, currently serving as Vice President. Dr. Cannon earned her Ph.D. in genetics from the University of Liverpool.

2021 Chroma Medicine. All rights reserved.
2021 Chroma Medicine. All rights reserved.